Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|September 15, 2016
Safety Study of Salmeterol in Asthma in AdultsTom Wilsdon, Ganessan Kichenadasse, Andrew Rowland
Clinical Pharmacology and Therapeutics|September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and EliminationAndrew Rowland, Zivile Useckaite, Michael J Sorich
Cellular and Molecular Life Sciences : CMLS|April 10, 2022
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseasesLauren A Newman, Kate Muller, Andrew Rowland
Plant Molecular Biology|May 2, 2006
Asparagales telomerases which synthesize the human type of telomeresEva Sýkorová, Andrew Rowland Leitch, Jirí Fajkus
Journal of Extracellular Biology|June 28, 2024
Addressing MISEV guidance using targeted LC-MS/MS: A method for the detection and quantification of extracellular vesicle-enriched and contaminant protein markers from bloodLauren A Newman, Zivile Useckaite, Andrew Rowland
Drug Metabolism and Pharmacokinetics|January 6, 2022
Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liabilityVerawan Uchaipichat, Andrew Rowland, John O Miners
British Journal of Clinical Pharmacology|November 4, 2017
Response to in vitro and physiologically-based pharmacokinetic assessment of the drug-drug interaction potential of canagliflozinJohn O Miners, Attarat Pattanawongsa, Andrew Rowland
BMC Medicine|September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availabilityAshley M Hopkins, Andrew Rowland, Michael J Sorich
British Journal of Clinical Pharmacology|February 1, 2013
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)Kathleen M Knights, Andrew Rowland, John O Miners
Melanoma Research|August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanomaMichael J Sorich, Andrew Rowland, Ashley M Hopkins
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|September 15, 2016
Safety Study of Salmeterol in Asthma in AdultsTom Wilsdon, Ganessan Kichenadasse, Andrew Rowland
Clinical Pharmacology and Therapeutics|September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and EliminationAndrew Rowland, Zivile Useckaite, Michael J Sorich
Cellular and Molecular Life Sciences : CMLS|April 10, 2022
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseasesLauren A Newman, Kate Muller, Andrew Rowland
Plant Molecular Biology|May 2, 2006
Asparagales telomerases which synthesize the human type of telomeresEva Sýkorová, Andrew Rowland Leitch, Jirí Fajkus
Journal of Extracellular Biology|June 28, 2024
Addressing MISEV guidance using targeted LC-MS/MS: A method for the detection and quantification of extracellular vesicle-enriched and contaminant protein markers from bloodLauren A Newman, Zivile Useckaite, Andrew Rowland
Drug Metabolism and Pharmacokinetics|January 6, 2022
Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liabilityVerawan Uchaipichat, Andrew Rowland, John O Miners
British Journal of Clinical Pharmacology|November 4, 2017
Response to in vitro and physiologically-based pharmacokinetic assessment of the drug-drug interaction potential of canagliflozinJohn O Miners, Attarat Pattanawongsa, Andrew Rowland
BMC Medicine|September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availabilityAshley M Hopkins, Andrew Rowland, Michael J Sorich
British Journal of Clinical Pharmacology|February 1, 2013
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)Kathleen M Knights, Andrew Rowland, John O Miners
Melanoma Research|August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanomaMichael J Sorich, Andrew Rowland, Ashley M Hopkins
Pageof 19